New uses for existing antiviral drugs

April 25, 2018

Zika virus. Ebola virus. Influenza. SARS and MERS corona viruses. Existing and emerging viral diseases are an increasing problem, particularly in developing countries. The World Health Organization has called for better control of viral diseases, but developing drugs for this purpose can be challenging.

Now, a multinational team of scientists and clinicians led by Denis Kainov from the Norwegian University of Science and Technology (NTNU) has reviewed all approved, investigational and experimental antiviral agents that have been shown to be safe in humans to search for new uses for these substances against existing and emerging viruses The results have just been published in Antiviral Research.

Antiviral drugs and vaccines are the most powerful tools to combat viral diseases. Most drugs and vaccines, however, selectively target a single virus, thereby providing a "one drug-one bug" solution, the researchers say.

In contrast, broad-spectrum antivirals (BSAs) can cover multiple viruses and genotypes and reduce the likelihood of development of resistance.

Therefore, some BSAs can be used for the rapid management of new or drug-resistant viral strains, for a first-line treatment or for prophylaxis of acute virus infections, as well as for viral co-infections, which can reduce the complexity of treatment.

With this in mind, the team identified 59 compounds already shown to be safe in humans that targeted at least three viral diseases. The researchers then tested 55 of these compounds on eight different viruses, and found that seven showed new effects against HIV-1, Zika virus and Rift Valley Fever.

"Re-purposing these therapeutics from one viral disease to another could save resources and time needed for development of novel drugs," Kainov said.

The researchers say that their results show existing safe-in-human BSAs could be used on other viral infections. The goal is to create broad-spectrum antiviral drugs, much like the broad-spectrum antibacterial drugs that are currently available.

"Effective treatment with broad-spectrum antivirals may shortly become available, pending the results of further pre-clinical studies and clinical trials. The most effective and tolerable compounds will expand the available therapeutics for the treatment of viral diseases," said Aleksandr Ianevsky, the first author of the study and a PhD student at NTNU.

"We hope that not only broad-spectrum antibiotics but also broad-spectrum antivirals will be available in a future," said Magnar Bjørås, a professor at NTNU's Department of Molecular Medicine. "These drugs could be used as first-line therapeutics to combat emerging and re-emerging viral threats that have a global impact, improving preparedness and the protection of the general population from viral epidemics and pandemics."
-end-
Reference: Aleksandr Ianevski, Eva Zusinaite, Suvi Kuivanen et al. Novel activities of safe-in-human broad-spectrum antiviral agents, Antiviral Research, Online 23 April 2018. https://doi.org/10.1016/j.antiviral.2018.04.016

Norwegian University of Science and Technology

Related Zika Virus Articles from Brightsurf:

'Domestication' increases mosquito's zika virus susceptibility
The Aedes aegypti aegypti subspecies of mosquito, which has become a ''domestic'' pest worldwide, can acquire and transmit Zika virus more easily than its African forerunner.

Greater mosquito susceptibility to Zika virus fueled the epidemic
By experimentally comparing wild populations of Ae. aegypti the researchers discovered that the invasive subspecies is very effective at transmitting the Zika virus not only because it has more frequent contacts with humans for blood meals, but also as a result of its greater susceptibility to the virus relative to the African subspecies.

Unravelling mother to baby transmission of Zika virus
Researchers have discovered that when a pregnant mother is infected by Zika virus, it can remain in the placenta for months, causing damage that can be dangerous to the fetus.

Consequences of Zika virus attack on glial cells
Few studies have identified the effects of zika virus infection on astrocytes, as well as their association with developmental alterations, including brain malformations and microcephaly.

Breakthrough in Zika virus vaccine
Researchers from the University of Adelaide have made significant advances in developing a novel vaccine against Zika virus, which could potentially lead to global elimination of the disease.

How the Zika virus can spread
The spread of infectious diseases such as Zika depends on many different factors.

Prior Zika virus or dengue virus infection does not affect secondary infections in monkeys
Previous infection with either Zika virus or dengue virus has no apparent effect on the clinical course of subsequent infection with the other virus, according to a study published August 1 in the open-access journal PLOS Pathogens by David O'Connor of the University of Wisconsin-Madison, and colleagues.

Early dengue virus infection could "defuse" zika virus
The Zika virus outbreak in Latin America has affected over 60 million people up to now.

Long-term consequences of Zika virus infection
Mice exposed to the Zika virus during later stages of gestation present behaviors reminiscent of attention-deficit/hyperactivity disorder, according to a study of genetically diverse animals.

Protection from Zika virus may lie in a protein derived from mosquitoes
By targeting a protein found in the saliva of mosquitoes that transmit Zika virus, Yale investigators reduced Zika infection in mice.

Read More: Zika Virus News and Zika Virus Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.